ASCO 2025 – Metastatic Breast Cancer Summary
burpeejump 2025-07-27 20:55:16
ASCO 2025 – Metastatic Breast Cancer SummaryHR+/HER2- mBC: Moving Beyond CDK4/6 Inhibitors-- CAPItello-291: Capivasertib + fulvestrant improved PFS in endocrine-resistant HR+ mBC.-- CAMBRIA-1: Camizestrant (oral SE...
[ 閱讀全文 ]